Riskpilot← Back to searchSign inGet full accessCYBOTIX AS
ASActiveOrg 927434598Inkognito terrasse 5A, 0256 OsloComputer programming activities · NACE 6210Est. 20210 employees
Revenue 2025
NOK 0
EBITDA margin
—
-453% vs 2024
Equity ratio
-2498.5%
Financial strength
Net profit 2025
NOK -16K
-453% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -16K | -453% |
| Net profit | NOK -16K | -453% |
| Total assets | NOK 137 | -99% |
| Equity | NOK -3K | -127% |
| Employees | 0 | — |
Legal name
CYBOTIX AS
Org number
927434598
Legal form
Aksjeselskap
NACE code
6210 · Computer programming activities
Founded
30. juli 2021
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Selge varern tjenester og programvare innen dataindustrien. Selskapet skal primært utvikle data programvare.
Address
Inkognito terrasse 5A, 0256 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 100 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 0 | 0 | −14 | −3 | −16 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | 0 | −14 | −3 | −16 |
| Net financials | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | −14 | −3 | −16 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | 0 | −14 | −3 | −16 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 30 | 30 | 16 | 13 | 0 |
| Equity | 30 | 30 | 16 | 13 | −3 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 4 |
| Total debt | 0 | 0 | 0 | 0 | 4 |
EBITDA margin
-1629200.0%
This company
15.8%
Market median
-10311492% vs market
20212025
Equity ratio
-2498.5%
This company
38.2%
Market median
-6641% vs market
20212025
Return on equity
-1629200.0%
This company
18.4%
Market median
-8854448% vs market
20212025
Net profit margin
-1629200.0%
This company
8.1%
Market median
-20113680% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
1.04×
This company
0.62×
Market median
-68% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Vesoldi As | Company | 33.3% | 33.3% | 2022 |
Any14 As | Company | 33.3% | 33.3% | 2022 |
Systemically Designed As | Company | 33.3% | 33.3% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Any14 As
CYBOTIX AS Board members of CYBOTIX AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Terje Ugletveit | Board of Directors | 0 companies |
| Niloufar Gharavi | Board of Directors | 0 companies |
| Lars Andreas Reinertsen | Chairman | 0 companies |